Amphastar Pharmaceuticals director Anthony T. Pierce files initial beneficial ownership statement (Form 3)
AMPH•Initial Form 3 filing
- Amphastar Pharmaceuticals director Anthony T. Pierce filed an initial Form 3 with the SEC on July 13, 2026.
AMPH•AMPH•
